Aurotem 200 mg & 25 mg FC tablets
PDF Leaflet Revision Date: 03 February 2026
Clinical Summary
Quick overview from the medicine insert
Indication
For treatment of HIV-1 in adults and adolescents (u226512 years, u226535 kg).
Dosage (summary)
200 mg Emtricitabine and 25 mg Tenofovir Alafenamide once daily.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended in pregnancy; avoid breastfeeding.
Key Drug Interactions
- Anticonvulsants (e.g., carbamazepine, phenytoin)
- Antimycobacterials (e.g., rifampicin)
- St. John's wort
Contraindications
- Hypersensitivity to components
Common side effects
- Nausea
- Diarrhoea
- Fatigue
- Headache
- Dizziness
Counselling Points
- Take once daily with or without food.
- Monitor for liver function and signs of lactic acidosis.
- Use effective contraception.
Serious warnings
- Lactic acidosis
- Severe hepatomegaly
- Risk of hepatitis B exacerbation
Important Disclaimer
The Aurotem 200 mg & 25 mg FC tablets professional information leaflet below is the property of Aurobindo Pharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
